SB 1096: Regulation of Compounded Drug Products
GENERAL BILL by Brodeur
Regulation of Compounded Drug Products; Requiring the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products; requiring certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy’s information sharing network as required by the memorandum, etc.
Effective Date: Except as otherwise expressly provided in this act, this act shall take effect upon becoming a law
Last Action: 3/14/2022 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Last Action: 3/14/2022 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Senate Committee References:
- Health Policy (HP)
- Regulated Industries (RI)
- Rules (RC)
Bill History
| Date | Chamber | Action |
|---|---|---|
| 11/30/2021 | Senate |
• Filed |
| 12/13/2021 | Senate |
• Referred to Health Policy; Regulated Industries; Rules -SJ 73 |
| 1/11/2022 | Senate |
• Introduced -SJ 73 |
| 3/12/2022 | Senate |
• Indefinitely postponed and withdrawn from consideration |
| 3/14/2022 | Senate |
• Died in Health Policy |
